Shona L. Ray-Griffith
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
Also affiliated: Arkansas Children's Hospital (2017); Sparrow Hospital (2024); Novem (Netherlands) (2016)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shona L. Ray-Griffith's research focuses on maternal and perinatal health interventions, particularly concerning substance use during pregnancy and pain management. She has investigated the clearance of buprenorphine during pregnancy and its impact on neonatal outcomes. Ray-Griffith also studies perceptions of marijuana use among pregnant individuals and the receipt of reproductive safety data by these populations. Her work extends to pain management strategies, including a pilot telemedicine initiative for patients with chronic non-cancer pain in rural areas and an evaluation of a multidisciplinary pain care program in Arkansas. She has also examined psychiatric involvement in US Maternal Mortality Review Committees and the use of continuous fetal monitoring during electroconvulsive therapy.
Metrics
- h-index: 8
- Publications: 23
- Citations: 313
Selected Publications
-
Receipt of reproductive safety data among pregnant marijuana users and nonusers (2026)
-
Time to pay attention: an underrecognized casualty of the opioid epidemic (2023)
-
Implementation and Preliminary Effectiveness of a Multidisciplinary Telemedicine Pilot Initiative for Patients with Chronic Non-Cancer Pain in Rural and Underserved Areas at a Major Academic Medical Center (2023)
-
Psychiatric participation in US Maternal Mortality Review Committees (2022)
-
Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder (2022)
-
A program evaluation of Arkansas Improving Multidisciplinary Pain Care and Treatment (AR-IMPACT) (2021)
-
Clearance of buprenorphine during pregnancy and neonatal outcomes (2021)
-
Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study (2021)
-
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention (2020)
-
Drug screening during pregnancy: Urine dip cups measure up (2019)
-
Chronic Pain Prevalence and Exposures during Pregnancy (2019)
-
Claims for contraceptive services among young women filling chronic opioid prescriptions (2019)
-
Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence (2018)
-
Fetal assessment in buprenorphine‐maintained women using fetal magnetoencephalography: a pilot study (2018)
-
Chronic pain during pregnancy: a review of the literature (2018)
Collaboration Network
Top Collaborators
- Time to pay attention: an underrecognized casualty of the opioid epidemic
- Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
- Psychiatric participation in US Maternal Mortality Review Committees
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Time to pay attention: an underrecognized casualty of the opioid epidemic
- Psychiatric participation in US Maternal Mortality Review Committees
- Receipt of reproductive safety data among pregnant marijuana users and nonusers
- Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
- Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
- Continuous Fetal Monitoring During Electroconvulsive Therapy: A Prospective Observation Study
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Clearance of buprenorphine during pregnancy and neonatal outcomes
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder
- Implementation and Preliminary Effectiveness of a Multidisciplinary Telemedicine Pilot Initiative for Patients with Chronic Non-Cancer Pain in Rural and Underserved Areas at a Major Academic Medical Center
Similar Researchers
Based on overlapping research topics